Bishal Gyawali, Associate Professor at Queen’s University, shared a post by BG Lab on X:
“We had quite a productive month in August at BG Lab. Follow along this thread for a quick summary of what we were up to.”
Quoting BG Lab’s post:
“We had a very productive August. Please tag along for an update on the major accomplishments from our team in August.
1. Our visiting colleague Laure-Anne Teuwen published an editorial in JNCI about clinical versus statistical significance.
2. Our Common Sense Oncology fellow Sam Stevens published a commentary in ACS Journal Cancer highlighting the need for precision in dosing, endpoints and trial reporting in the context of codebreak 300 trial.
Our visiting colleague Laure-Anne Teuwen published another editorial in BMJ Oncology discussing the control arms in clinical trials run in LMICs.
Our team leader Bishal Gyawali discussed the intersection of CSO and precision oncology in this piece published in Marathon of Hope Cancer Centres Network.
We received news that our ASCO Ed Book Chapter based on the session that Bishal Gyawali chaired at ASCO25 was among the most downloaded articles for 2025.
Last but important, Bishal Gyawali was awarded by Canadian Cancer Society with the William E. Rawls Prize for excellence in cancer research.”
More posts featuring Bishal Gyawali on OncoDaily.